heart disease
The company, which received CE marking for its high sensitivity troponin I assay and Atellica VTLi Patient-side Immunoassay Analyzer, plans to enter the US market.
Quest Diagnostics, Zora Biosciences Sign Licensing Agreement for Cardiovascular Biomarkers
The company signed a non-exclusive license for Zora's ceramide markers and plans to launch a test based on the markers as early as next year.
Proxim Diagnostics Developing Handheld Analyzer for Point-of-Care, SARS-CoV-2 Testing
The firm is developing a test to determine interleukin-6 levels for SARS-CoV-2 patients and a rapid antigen test.
Wyss Institute Developing Multiplex Electrochemical Testing Platform for Multiple Disease Conditions
The iQ Group Global is integrating the Wyss Institute's technology with its own organic thin-film biosensor platform for SARS-CoV-2 serology testing.Â
AACC, CDC to Expand Lipid Testing Globally
The partnership will provide new point-of-care lipid testing devices to remote sites in Latin America, the Caribbean, and Asia-Pacific.
Jan 28, 2020
Oct 2, 2019
Aug 14, 2019
Salveo Dx Merges With ImmunArray, Nudge
Jun 4, 2019
Nov 15, 2018
Oct 31, 2018
Diagnostics Firm 1Drop Raises $4.25M
Oct 8, 2018